How to build and implement an eQMS: efficiency, compliance and data integrity – Replay

News

Streamlining Medical Device Risk Analysis with GxpManager's Agile Platform

Article published on DeviceMed.

A medical device’s risk analysis is an essential step in ensuring that it complies with current regulations and is safe for users. In this field, digitizing critical data helps ensure data compliance, safety, and reliability.

 

Medical devices are subject to strict regulations (EU 2017/745, ISO14971, 21CFR part 11…) to guarantee their effectiveness and patient safety. In turn, these texts require compliance with demanding standards for medical device design, manufacture, packaging, labeling, and use. The risk analysis process involves studying past risks and identifying and assessing potential threats to determine the measures to minimize these risks.

There are ways in which these can be assessed, including using risk management solutions that identify weak points and draw up mitigation plans to alleviate them. The aim is to ensure that the risks associated with the use of medical devices, whatever their class, are reduced to an acceptable level, and that the benefits of the device outweigh the risks. The risk management process comprises several stages:

  • Risk identification,
  • Assessing them in terms of probability of occurrence and severity,
  • Controlling unaccepted risks by implementing corrective actions,
  • Assessment of residual and/or collateral risks.

This is a critical process. Yet it is often formalized in Excel spreadsheets, which do not comply with current security, data integrity, and traceability regulations.

An agile platform that facilitates audits

GxpManager offers its “Risk Analysis” application to meet this need. This solution includes a set of customizable, compliance-oriented functionalities that are ideally suited to risk analysis of medical devices.

It manages the entire risk management process and automatically publishes the file: identification, assessment, control, acceptability, graphic indicators, etc. The application is customized to each manufacturer’s processes and methods. It features native functionalities such as audit trail, document versioning, workflows with electronic signatures, one-click report publication, and much more…

This agile platform supports manufacturers in the digitization of their critical data. It reduces document management effort, centralizes and shares data, automates processes, enables real-time reporting, and allows controlled publication of risk management files according to manufacturers’ templates.

The message from GxpManager President Jérôme Tomaselli is clear:

“Digitizing the risk analysis process for medical devices can present a daunting challenge, but traceability, compliance, and safety benefits are considerable.”

Other news

News
Do regulated companies really have control over the traceability of their critical data?

During an inspection, untraceable data can undermine the integrity of your entire quality system. In regulated sectors, traceability is no longer optional: it is a strategic lever to secure your products, manage risks, and ensure compliance.

Learn more
News
Non-conformance: How to Manage Non-compliance with Optimized Digital Management?

In industries such as pharmaceuticals, medical devices, or agri-food, every non-compliance can severely impact quality, safety, and regulatory compliance. Learn why non-conformance management should no longer be optional but a strategic pillar of your quality system.

Learn more
News
GxpManager revolutionizes laboratory data management at Forum LABO Paris 2025.

GxpManager invites you to Forum LABO 2025, from March 25 to 27 at Paris Expo Porte de Versailles (stand B042)! Discover how our solution simplifies data management, ensures traceability, and automates quality processes in laboratories. Attend live demonstrations and engage with our experts to optimize your workflows.

Learn more